The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.50
Bid: 133.00
Ask: 136.00
Change: -2.50 (-1.82%)
Spread: 3.00 (2.256%)
Open: 135.00
High: 134.50
Low: 133.00
Prev. Close: 137.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Sep 2020 12:20

RNS Number : 2009Z
Eurocell plc
16 September 2020
 

16 September 2020

 

Eurocell plc

 

Director/PDMR Shareholding

 

Eurocell plc (the "Company") announces that, on 9 September 2020, options were granted under the Eurocell plc Deferred Share Plan 2015 to 2 directors (in relation to the deferred element of the 2019 Annual bonus).

 

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Kelly

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire shares under the Eurocell plc Deferred Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£nil (option price)

26,863

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transaction

e)

Date of the transaction

9 September 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Michael Scott

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire shares under the Eurocell plc Deferred Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£nil (option price)

17,162

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transaction

e)

Date of the transaction

9 September 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

For further information:

 

Eurocell plc 01773 842 100

Paul Walker

Group Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUMGBUPUGGQ
Date   Source Headline
22nd Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSPublication of 2023 Annual Report & Notice of AGM
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:01 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20244:30 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSInvestor Presentation
20th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSBlock listing Interim Review
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.